Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Valerian root dry extract, derived from the roots of *Valeriana officinalis*, is a herbal preparation widely utilized for its sedative, anxiolytic, and sleep-promoting properties. Its pharmacological activity is primarily attributed to constituents such as valerenic acids, valepotriates, and flavonoids, which interact with the central nervous system's GABAergic pathways. Specifically, valerenic acid acts as a positive allosteric modulator of GABA-A receptors and inhibits the enzyme GABA transaminase, leading to increased synaptic concentrations of GABA and subsequent CNS depression. Researchers at the Medical University of Graz have specifically investigated the use of standardized valerian root dry extract for the prevention and management of perioperative anxiety and pain, positioning it as a potential natural alternative to benzodiazepines in the surgical setting. It is also commonly marketed globally as a traditional herbal medicine or dietary supplement for insomnia and restlessness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on valerian root dry extract.